Abstract
We report a patient with prostate cancer found 2 years after percutaneous arterial embolization (PAE) of the prostate with a rapid increase in prostate specific antigen (PSA) 3 months later, even though the initial result was low. He did not consult a urologist during or after PAE until acute urinary retention developed. The clinical stage was cT2cN1M1b with Gleason grade 5 + 5 = 10. An increase in PSA a short interval after PAE may suggest the presence of prostate cancer. We suggest that patients undergoing PAE should consult a urologist, and that PSA levels should be checked every 3 months in the first year after PSA.
Funder
Taiwan Ministry of Science and Technology
China Medical University Hospital
Reference29 articles.
1. Saito, S., Koyama, Y., Ueda, J., and Hashido, T. (2022). Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia. Diagnostic, 12.
2. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction;Eur. Urol.,2015
3. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I, Initial Work-up and Medical Management;J. Urol.,2021
4. Rezum Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study;Urology,2019
5. Efficacy and safety of the urolift(R) system for the treatment of benign prostate hyperplasia symptoms: Systematic review;Actas. Urol. Esp.,2015